Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 198

Results For "SEC"

3011 News Found

There should be no space for fraud in AB-PMJAY: Dr. Mandaviya
Policy | September 27, 2022

There should be no space for fraud in AB-PMJAY: Dr. Mandaviya

The second day of Arogya Manthan 2022 had panel discussions with eminent thought leaders from relevant public and private sector organizations


Hester planning capacity expansion for Goat Pox vaccine
News | September 27, 2022

Hester planning capacity expansion for Goat Pox vaccine

Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine


Alkem to spread awareness through “The Healthy Lungs”
Healthcare | September 26, 2022

Alkem to spread awareness through “The Healthy Lungs”

Though lungs do not have the celebrity status as the heart, they are one of the most important and delicate organs of the human body


AIIMS New Delhi celebrates 67th Foundation Day
News | September 26, 2022

AIIMS New Delhi celebrates 67th Foundation Day

India's healthcare system has shown great efficiency not only in providing diagnostic and management facilities but also in minimizing mortality and maximizing recovery


Cadila and CII launches joint national campaign for rabies-free India by 2030
Public Health | September 24, 2022

Cadila and CII launches joint national campaign for rabies-free India by 2030

Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone


19 crore AB-PMJAY cards created; 3.8 crore beneficiaries avails free benefit
Policy | September 24, 2022

19 crore AB-PMJAY cards created; 3.8 crore beneficiaries avails free benefit

AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds


U.S. District Court rules in favor of Merck in Sitagliptin Phosphate patent lawsuit
News | September 23, 2022

U.S. District Court rules in favor of Merck in Sitagliptin Phosphate patent lawsuit

Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR


KDAH receives SMART ICU certification after pandemic
News | September 23, 2022

KDAH receives SMART ICU certification after pandemic

Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification


JB Pharma witness 20% growth in August 2022: IQVIA
News | September 22, 2022

JB Pharma witness 20% growth in August 2022: IQVIA

Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.


NATCO gets CTPR launch approval from Delhi High Court
News | September 21, 2022

NATCO gets CTPR launch approval from Delhi High Court

NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole